Roivant Sciences Financial Overview
Roivant Sciences's market cap is currently $14.60B. The company's EPS TTM is $-0.202; its P/E ratio is ―; Roivant Sciences is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
